|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/713 | |||
| C07H 21/02 | |||
| A61P 27/02 | |||
| A61P 3/10 | |||
| A61P 11/00 |
| (11) | Number of the document | 1791568 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05786796.2 |
| Date of filing the European patent application | 2005-08-16 | |
| (97) | Date of publication of the European application | 2007-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/029236 |
| Date | 2005-08-16 |
| (87) | Number | WO 2006/023544 |
| Date | 2006-03-02 |
| (30) | Number | Date | Country code |
| 04019405 | 2004-08-16 | EP | |
| 601983 P | 2004-08-17 | US | |
| 604668 P | 2004-08-25 | US | |
| 609786 P | 2004-09-14 | US | |
| 638659 P | 2004-12-22 | US | |
| 664236 P | 2005-03-22 | US | |
| 688943 P | 2005-06-08 | US |
| (72) |
FEINSTEIN, Elena, IL
KAUFMANN, Jörg, c/o Atugen AG, DE
GIESE, Klaus, DE
|
| (73) |
Quark Pharmaceuticals, Inc.,
6501 Dumbarton Circle, Fremont, California 94555,
US
Silence Therapeutics Aktiengesellschaft, Robert-Rössle-Strasse 10, 13125 Berlin, DE |
| (54) | THERAPEUTIC USES OF INHIBITORS OF RTP801 |
| THERAPEUTIC USES OF INHIBITORS OF RTP801 |